These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5505819)

  • 1. [Inhibition of the contractility of the pregnant human uterus through the use of orciprenaline sulfate and Th-1165].
    Cobo E; Kafury S
    Rev Colomb Obstet Ginecol; 1970; 21(3):271-2. PubMed ID: 5505819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of orciprenaline as an inhibitor of uterine contractility].
    Soto Yances A
    Rev Colomb Obstet Ginecol; 1970; 21(3):219-31. PubMed ID: 5505816
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of orciprenaline in the last stage of dilatation in labor].
    Lima JR; Montenegro CA; Yamashiro RT
    Matern Infanc (Sao Paulo); 1972; 31(1):43-51. PubMed ID: 5049154
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of orciprenaline on uterine contractility].
    Guevara-Rubio G; Castillo Sosa ML; Karchmer S; Guzmán Sánchez A
    Ginecol Obstet Mex; 1971 Mar; 29(173):301-18. PubMed ID: 5088897
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of beta-mimetic adrenergic drugs on the activity of the pregnant human uterus, tested with the intra-uterine pressure method.
    Eskes T; Seelen J; van Gent I
    Arzneimittelforschung; 1966 Jun; 16(6):762-6. PubMed ID: 6014589
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with orciprenaline in obstetrics. Biophysical and hematochemical studies at the maternal and fetal level].
    Picinelli G; Gaioni L; Picinelli ML; Angiolillo M
    Ann Ostet Ginecol Med Perinat; 1973 Jan; 94(1):28-43. PubMed ID: 4767625
    [No Abstract]   [Full Text] [Related]  

  • 7. [Orciprenaline (Alupent) for pharmacological relaxation of the uterus during labor].
    Melander S
    Nord Med; 1971 Aug; 86(33):985. PubMed ID: 5094859
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular action of orciprenaline in the pregnant woman and the fetus].
    Guevara Rubio G; Castillo Sosa ML; Smith HC; Karchmer S
    Ginecol Obstet Mex; 1972 Apr; 31(186):389-95. PubMed ID: 5028606
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of orciprenaline in labor].
    Pardi G; Figini E
    Ann Ostet Ginecol Med Perinat; 1972 Mar; 93(3):152-60. PubMed ID: 4675116
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of labour by hydroxyphenyl-orcipeualin-aerosol (Th 1165 a, fenoterol) (author's transl)].
    Zahn V
    Geburtshilfe Frauenheilkd; 1973 Oct; 33(10):818-21. PubMed ID: 4767408
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative tocography studies using various tocolytic substances].
    Schnell JD; Stockhausen H
    Arch Gynakol; 1971 Jun; 211(1):277-8. PubMed ID: 5108883
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of spinal anesthesia on pregnant human uterine contractility. II. Effects during labor (1st and 2nd stages).
    Neme B
    Matern Infanc (Sao Paulo); 1971; 30(2):189-202. PubMed ID: 5143568
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of spinal anesthesia on pregnant human uterine contractility. 3. Effects during labor (3rd stage) and immediate post-partum (4th stage).
    Neme B
    Matern Infanc (Sao Paulo); 1971; 30(2):203-10. PubMed ID: 5143569
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-experimental studies on the use of orciprenaline in labor].
    Sani G; Belvederi GD; Facchini V; La Marca S
    Minerva Ginecol; 1975 Aug; 27(8):638-47. PubMed ID: 1221323
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological studies of the pregnant human uterus. I. Effects of hydergine].
    Gomez C; Vicuña JE; Guiloff E
    Rev Chil Obstet Ginecol; 1965; 30(5):283-92. PubMed ID: 4964126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of orciprenaline on the contractility of the pregnant uterus and on the fetal cardiac rhythm].
    Pontonnier G; Tournier C; Dat S; Delmas H; Favarel E
    Gynecol Obstet (Paris); 1971; 70(2):157-63. PubMed ID: 5563843
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of the contractility of the uterus in threatened premature labor using orciprenaline (Alupent). Preliminary report].
    Cobo E; Kafury S
    Rev Colomb Obstet Ginecol; 1970; 21(2):111-7. PubMed ID: 5450670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological studies of the pregnant human uterus. II. Pharmacological evaluation of orally administered oxytocin].
    Gomez C; Guiloff E; Ibarra-Polo AA; Quintanilla R; Foxley R; Pupkin M; Muñoz F
    Rev Chil Obstet Ginecol; 1965; 30(5):293-304. PubMed ID: 5896453
    [No Abstract]   [Full Text] [Related]  

  • 19. On the influence of orciprenaline on uterine motility and on plasma levels of estradiol-17 beta in pregnant and parturient sheep.
    Bontekoe EH; Blacquière JF; Naaktogeboren C; Dieleman SJ
    Eur J Obstet Gynecol Reprod Biol; 1980 Jan; 10(1):55-67. PubMed ID: 7189160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of uterine contraction on the fetus].
    Erny R
    Mars Med; 1972; 109(1):71-5. PubMed ID: 5018835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.